Steroids and Immunomodulatory Therapies for Acute Respiratory Distress Syndrome

This publication has 103 references indexed in Scilit:

• Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies
  Intensive Care Medicine, 2020
• Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung
  Intensive Care Medicine, 2020
• Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome
  JAMA, 2020
• The molecular details of cytokine signaling via the JAK/STAT pathway
  Protein Science, 2018
• Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study
  Intensive Care Medicine, 2018
• Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials
  Intensive Care Medicine, 2016
• Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries
  JAMA, 2016
• Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases
  European Journal of Immunology, 2006
• Corticosteroid Use in the Intensive Care Unit
  Archives of Surgery, 2006
• Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome
  JAMA, 1998